Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 2214 record(s)

Req # A-2020-000946

Information for how many applications have been filed and currently are pending for an Exemption To Use A Controlled Substance. Also how many approvals have been made for exemption of Section 56(1) for sacrament use.

Organization: Health Canada

1 page(s)
February 2021

Req # A-2020-001058

Records regarding the processing of access to information requests during the COVID-19 pandemic involving the Minister of Health, Minister’s Staff, and the Minister’s Office from July 1, 2020 to November 2, 2020.

Organization: Health Canada

56 page(s)
February 2021

Req # A-2020-001156

All documents and internal/external communication regarding a contract worth $371,318,000 and a contract worth $17,498,050 awarded to Proline Advantage Inc. from February 1, 2020 to November 13, 2020.

Organization: Health Canada

7 page(s)
February 2021

Req # A-2020-001210

All records to Health Canada from Novartis or submissions made by Novartis to Health Canada concerning the standards and criteria that should be applied by Health Canada when assessing the bioequivalence and/or bioavailability of octreotide acetate suspension products for approval, when such products rely upon the approval of Novartis’ drug. Time frame would be any time after January 1, 2015.

Organization: Health Canada

0 page(s)
February 2021

Req # A-2020-001416

All records, sent/rec'd by officials the Director General (DG), Assistant Deputy Minister (ADM) or Deputy Minister (DM) level regarding the contract with Proline Advantage Inc detailed in this news story https://www.cbc.ca/news/business/ppe-covid-coronavirus-personal-protective-equipment-politics-1.5831340 From March 2020 to December 16th 2020.

Organization: Health Canada

0 page(s)
February 2021

Req # A-2020-001417

The final versions of all Briefing Notes regarding Elmiron.

Organization: Health Canada

8 page(s)
February 2021

Req # A-2020-001437

All data relating to the DNA of COVID19, data on the Covid19 particle relating to the Exosomes in the human DNA, data of all viruses that can be passed on by Air/Particles, data that RT PCR test kits measure any type of Virus or measures exosomes only, information on the e use of the Guthrie card trial DNA Bio-Medical barcode and non consented Guthrie card trail DNA Bio-Medical barcode.

Organization: Health Canada

0 page(s)
February 2021

Req # A-2020-000429

Adverse Drug Reaction (ADR) for botulinum toxin brand name. Report number: E2B_03008733.

Organization: Health Canada

8 page(s)
February 2021

Req # A-2020-001625

Summaries of published scientific evidence related to the harms and benefits of using vaping products which were prepared or updated by the Research Division or Policy Division of the Tobacco Control Directorate of Health Canada between July 1, 2020 and December 31, 2020.

Organization: Health Canada

0 page(s)
February 2021

Req # A-2020-001659

Get details on all procedures, requests or recourse that are active or ongoing, or any balance that is due to you from the Corporation: 183318 Canada inc. (NEQ 1169205169) Addresses: 4625 3rd Avenue West, Québec City, QC G1H 6E7; 4675 3rd Avenue West, Québec City, QC G1H 6E8

Organization: Health Canada

0 page(s)
February 2021
Date modified: